Oxford Immunotec Global PLC Shares Approach 52-Week High - Market Mover

The shares closed 1.6% below its 52-week high of $22.29, with trading volume higher than its 30 day average

Jan 15, 2021 by Kwhen Finance Editors

Oxford Immunotec Global PLC Shares Approach 52-Week High - Market Mover
Oxford Immunotec Global PLC shares closed today at 1.6% below its 52 week high of $22.29, giving the company a market cap of $569M. The stock is currently up 25.6% year-to-date, up 35.3% over the past 12 months, and up 112.4% over the past five years. This week, the Dow Jones Industrial Average fell 0.9%, and the S&P 500 fell 1.5%.

Trading Activity

  • Trading volume this week was 10.4% lower than the 20-day average.
  • Beta, a measure of the stock’s volatility relative to the overall market stands at 0.7.

Technical Indicators

  • The Relative Strength Index (RSI) on the stock was above 70, indicating it may be overbought.
  • MACD, a trend-following momentum indicator, indicates a downward trend.
  • The stock closed above its Bollinger band, indicating it may be overbought.

Fundamentals & Catalysts

  • Over the past 12 months the company generated $-3,260,000 in earnings before interest and taxes from $73 million in revenue. It currently holds $181 million in cash and $984,000 in debt.
  • Its forward price-to-earnings (P/E) ratio of -20.33 is lower than its current P/E ratio of 0.00, implying that analysts are expecting an increase in earnings.
  • The company's price/earnings-to-growth ratio (PEG Ratio), a widely used indicator of a stock's true value while also factoring in expected earnings growth, currently stands at 0.01. A fairly valued company should have a PEG ratio of 1.0. When a company's PEG exceeds 1.0, it's considered overvalued while a stock with a PEG of less than 1.0 is considered undervalued.
  • The company's debt-to-equity ratio, which measures the extent to which it finances its operations through debt, currently stands at 0.04 which means it currently has $0.04 of debt for every $1 of equity. Generally speaking, a debt to equity ratio below 1.0 is seen as relatively safe, while ratios of 2.0 or higher would be considered risky. Some industries are known for having much higher debt to equity ratios than others.
  • The company's price-to-book ratio, which measures the market's valuation of a company relative to its book value, currently stands at 1.70. This means that the stock is trading at a premium of 2 times relative to the company's book value which reflects the total value of a company's assets that shareholders of that company would receive if the company were to be liquidated.
  • The company's price-to-sales ratio, which shows how much the market values every dollar of the company's sales, currently stands at 4.94.
  • The company's enterprise value-to-revenue multiple, which is often used to determine a company's valuation in the case of a potential acquisition, currently stands at 2.60.

P/E

0.00

EBITDA

$-3,260,000

P/Book

1.70

Mkt Cap

$569M

P/Sales

4.94

Revenue

$73M

EPS (TTM)

0.00

PEG Ratio

0.01

EV/Revenue

2.60

Total Cash

$181M

Debt/Equity

0.04

Forward P/E

-20.33

Current Debt

$984,000

Gross Profit

$54M

Dividend Date

-

Earnings Date

-

Profit Margin

-0.02

Revenue/Share

2.84

Total Revenue

$73M

Enterprise Val

$191M

Put/Call Ratio

0.50

Revenue/Employee

303333.33

Market Comparative Performance

  • The company's share price is the same as the S&P 500 Index , beats it on a 1-year basis, and lags it on a 5-year basis
  • The company's share price is the same as the Dow Jones Industrial Average , beats it on a 1-year basis, and lags it on a 5-year basis
  • The company share price is the same as the performance of its peers in the Health Care industry sector , beats it on a 1-year basis, and beats it on a 5 year basis
NameDoD %ΔYTD %Δ1 Yr %52-Week H %52-Week L %
Oxford Immunotec Global PLC-0.025.635.3-1.5139.9
Dow Jones Industrial Average-0.60.87.5-0.968.1
S&P 500 Index-0.70.515.7-1.271.1
Health Care0.23.416.0-1.360.7

Peer Group Comparative Performance

  • The company's stock priceperformance year-to-date beats the peer average by 285.4%
  • The company's stock price performance over the past 12 months lags the peer average by -40.2%
NameMKT CAP (USD)P/EYTD %Δ1 Yr %Δ52-Week H %52-Week L %
Oxford Immunotec Global PLCOXFD025.635.3-1.5139.9
Peer AvgN/A10.86.659.1-25.2126.3
Quidel CorporationQDEL23.213.8173.1-33.8170.4
Meridian Bioscience Inc.VIVO20.215.5115.9-16.6295.3
Psychemedics CorporationPMD0-2.8-52.5-50.539.2

This story was produced by the Kwhen Automated News Generator. For more articles like this, please visit us at finance.kwhen.com. Write to editors@kwhen.com. © 2021 Kwhen Inc.

Was this content valuable for you?

Tags: